在评估系统性红斑狼患者的疾病活性时SLE-DAS的价值:单中心回顾性研究
Jinlu Ma1, Lin Zhang1, Mengxue Yan1
1Department of Rheumatology and Immunology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Lupus science & medicine
|June 11, 2024
概括
系统性红斑狼疾病活动评分 (SLE-DAS) 显示,有望更准确地评估系统性红斑狼 (SLE) 患者的疾病活动. 这一得分与SLE疾病活动指数2000 (SLEDAI 2000) 相比,与治疗和特定严重疾病的相关性更好.
科学领域:
- 类风湿病学 类风湿病学
- 临床免疫学临床免疫学
- 系统性红斑狼 (SLE) 研究研究
背景情况:
- 准确评估疾病活动对于管理系统性红斑狼 (SLE) 至关重要.
- 现有的评分系统可能在反映疾病活动和治疗反应的全谱方面存在局限性.
- 系统性狼发疹病活动评分 (SLE-DAS) 是改善SLE活动评估的潜在工具.
研究的目的:
- 评估系统性狼红斑血病活动评分 (SLE-DAS) 在评估SLE患者疾病活动中的临床实用性.
- 将SLE-DAS的表现与已建立的SLE疾病活动指数2000 (SLEDAI 2000) 进行比较.
主要方法:
- 从2009年1月至2022年12月期间收集了396名SLE患者的临床数据.
- 葡萄糖皮质醇剂量分级被用作SLE疾病活性评估的黄金标准.
- 使用斯皮尔曼相关性分析来比较SLE-DAS和SLEDAI 2000与临床变量和治疗数据.
主要成果:
- SLE-DAS与SLEDAI 2000 (ρ=0.709,p<0.001) 显示出强烈的相关性.
- 与SLEDAI 2000相比,SLE-DAS与葡萄糖皮质激素剂量,马球蛋白使用和免疫抑制剂使用的相关性更好.
- 与SLEDAI 2000不同,SLE-DAS与严重的血小板缺血,心脏和肺部干扰相关.
结论:
- 系统性红斑狼疾病活动评分 (SLE-DAS) 似乎可以更准确地评估SLE患者的疾病活动.
- SLE-DAS可能特别有价值,用于评估严重血小板缺血和心肺表现的患者的疾病活性.
- 在不同的SLE群体中进一步验证SLE-DAS是合理的.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Nephrotic Syndrome II : Assessment and Medical Management
422
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422


